» Asbestos Exposure
» Asbestos Litigation
» Asbestos Side Effects
» Clinical Trials
» Coping With...
» New Treatments
» Diagnosing
» Prognosis
» Statistics & Facts
» Traditional Treatments
» Types of Mesothelioma
» Who Is At Risk
For immediate assistance call: (800) 654-1475
For some patients, participation in a mesothelioma clinical trial may offer new hope in the face of a poor prognosis. Mesothelioma is an aggressive disease, and treatment options for advanced cases are limited.
Mesothelioma clinical trials allow researchers to learn whether a new medication or procedure is effective and safe for use in humans. Studies of human subjects are a front-line weapon in the quest to find treatments and cures for mesothelioma and other cancers.
No one knows in advance how a mesothelioma clinical trial will turn out - that is what makes a trial necessary. And that is what makes choosing whether or not to participate in a clinical trial one of the toughest and most personal decisions facing a person with mesothelioma. There is no right or wrong choice; no single solution for all patients.
As in any decision-making process, there are steps mesothelioma patients can take to help them decide whether or not to participate in a clinical trial. The first step is to take an honest, critical look at the general benefits and risks of being a test subject.
If you have mesothelioma and are wondering whether you might benefit from participating in a mesothelioma clinical trial, you may wish to talk to your doctor. He or she can tell you whether a clinical trial is a viable option for you and help you identify trials for which you may be qualified.
You can also explore the option of mesothelioma clinical trials on the Internet. ClinicalTrials.gov is a website provided by the National Institutes of Health that offers a searchable database where patients can find information on current trials. The National Cancer Institute (www.cancer.gov) and the American Cancer Society (www.cancer.org) offer similar services.